BioMarin Pharmaceutical, Inc.

( )
BMRN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
GILDGilead Sciences, Inc. -0.81%67.011.0%$1018.93m
BIIBBiogen, Inc. 1.23%337.101.5%$697.83m
AMGNAmgen, Inc. -0.80%221.691.3%$576.64m
ILMNIllumina, Inc. 0.34%299.923.5%$431.18m
REGNRegeneron Pharmaceuticals, Inc. -0.48%397.652.6%$376.00m
VRTXVertex Pharmaceuticals, Inc. 0.87%245.931.9%$347.90m
ALXNAlexion Pharmaceuticals, Inc. -0.39%102.162.0%$209.65m
EXASEXACT Sciences Corp. 1.45%99.6024.0%$166.34m
AAgilent Technologies, Inc. -1.19%84.801.6%$153.01m
SGENSeattle Genetics, Inc. 1.61%119.976.1%$118.55m
MRNAModerna, Inc. -0.47%18.910.0%$109.05m
INCYIncyte Corp. 1.08%79.302.5%$101.80m
XLRNAcceleron Pharma, Inc. 0.69%94.316.1%$97.26m
SRPTSarepta Therapeutics, Inc. -2.11%122.7814.6%$93.77m
ALNYAlnylam Pharmaceuticals, Inc. -0.02%128.688.7%$93.35m

Company Profile

BioMarin Pharmaceutical, Inc. is a biotechnology company, which develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its products include Aldurazyme, Brineura, Kuvan, Naglazyme, Palynziq and Vimizim. The company was founded by Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.